KATHRYN KINCAIDE: Open Payments
NPI 1639584790 · LEE'S SUMMIT, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$428 in 19 payments from 11 companies in 2025. Trend: 2023 $632 · 2024 $719 · 2025 $428
Food & beverage: $428
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 3 | $112 |
| AstraZeneca Pharmaceuticals LP | 4 | $80 |
| Grifols USA, LLC | 3 | $74 |
| Insmed, Inc. | 2 | $34 |
| United Therapeutics Corporation | 1 | $25 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $21 |
| Verona Pharma, Inc. | 1 | $20 |
| Azurity Pharmaceuticals, Inc. | 1 | $19 |
| Genentech USA, Inc. | 1 | $15 |
| Amgen Inc. | 1 | $14 |
Products named: DUPIXENT, Prolastin-C Liquid, Arikayce, BREZTRI, JASCAYD, Ohtuvayre, ALVESCO, FASENRA.
Industry payments across MO — which companies pay providers there.
